[Combination pharmacotherapy therapy in the management of atherogenic dyslipidemia].
Kłosiewicz-Latoszek
Longina
L
Akademia Medyczna, Warszawie.
Cybulska
Barbara
B
D000328:Adult; D000924:Anticholesteremic Agents / Q000008:administration & dosage; D050197:Atherosclerosis / Q000209:etiology / Q000517:prevention & control*; D002995:Clofibric Acid / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage; D000960:Hypolipidemic Agents / Q000008:administration & dosage; D009525:Niacin / Q000008:administration & dosage
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D009525:Niacin; D002995:Clofibric Acid